Ingelsson Erik
Transaction: 04/09/2026
OTHER
Change
+273,750
Price
$12.75
Filing
04/17/2026
Type
OTHER
Wave Life Sciences Ltd.
WVE • Biotechnology
$4.86
▲ +0.16 (+3.40%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$972.82M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Healthy liquidity · 6.47Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 28, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.86
Change3.40%
Shares Out200.17M
Market Cap$972.82M
Enterprise Value$436.55M
52W Range5.02 - 21.73
Beta-1.33
P/E-5.30
P/S13.55
P/B1.90
P/FCF-5.33
EV/Sales6.08
Price$4.86
Change3.40%
Shares Out200.17M
Market Cap$972.82M
Enterprise Value$436.55M
52W Range5.02 - 21.73
Beta-1.33
P/E-5.30
P/S13.55
P/B1.90
P/FCF-5.33
EV/Sales6.08
EV/EBITDA-2.40
EV/FCF-2.39
Earnings Yield-18.87%
FCF Yield-18.77%
Dividend Yield0.00%
Gross Margin79.28%
Oper. Margin-5.04%
Profit Margin-4.78%
Debt/Eq0.03
Current Ratio6.47
Quick Ratio6.47
Target$14.00
Target Upside188.07%
Target Median$13.00
Target Range12.00 - 18.00
Volume6.69M
Avg Volume4.04M
EPS Surprise0.21
Investment DNA
How strong this company looks for long-term investors
32
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
39/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 6.47Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 25 analyst votes · 2026-09-05
98/100
Bullish
Bullish
24
Hold
1
Bearish
0
Price Target
2026-06-29
Low
$13.00
Mean
$20.29
Median
$15.00
High
$43.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Ingelsson Erik
Transaction: 04/09/2026
OTHER
Change
0
Price
Not reported
Filing
04/17/2026
Type
OTHER
Wright Christopher I
Transaction: 04/09/2026
OTHER
Change
+273,750
Price
$12.75
Filing
04/17/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Ingelsson Erik | OTHER | +273,750 | $12.75 | 04/09/2026 | 04/17/2026 |
| Ingelsson Erik | OTHER | 0 | Not reported | 04/09/2026 | 04/17/2026 |
| Wright Christopher I | OTHER | +273,750 | $12.75 | 04/09/2026 | 04/17/2026 |
| Wright Christopher I | OTHER | 0 | Not reported | 04/09/2026 | 04/17/2026 |
| RA CAPITAL MANAGEMENT, L.P. | BUY | +971,091 | $6.50 | 03/30/2026 | 03/30/2026 |
| RA CAPITAL MANAGEMENT, L.P. | BUY | +2,495,623 | $6.43 | 03/27/2026 | 03/30/2026 |
| RA CAPITAL MANAGEMENT, L.P. | BUY | +4,954,558 | $6.06 | 03/26/2026 | 03/30/2026 |
| TAKANASHI KEN | SELL | -3,901,348 | Not reported | 03/23/2026 | 03/26/2026 |
| TAKANASHI KEN | BUY | +3,901,348 | Not reported | 03/23/2026 | 03/26/2026 |
| Francis Chris | SELL | -15,294 | $15.00 | 02/26/2026 | 02/27/2026 |
| Francis Chris | SELL | -15,294 | $4.75 | 02/26/2026 | 02/27/2026 |
| Vargeese Chandra | SELL | -3,228 | $13.45 | 02/09/2026 | 02/11/2026 |
| Francis Chris | SELL | -1,883 | $13.45 | 02/09/2026 | 02/11/2026 |
| BOLNO PAUL | SELL | -10,480 | $13.45 | 02/09/2026 | 02/11/2026 |
| Moran Kyle | SELL | -3,588 | $13.45 | 02/09/2026 | 02/11/2026 |
| Vargeese Chandra | BUY | +273,750 | $12.75 | 02/05/2026 | 02/11/2026 |
| Vargeese Chandra | BUY | +45,625 | Not reported | 02/05/2026 | 02/11/2026 |
| Francis Chris | BUY | +38,750 | Not reported | 02/05/2026 | 02/11/2026 |
| Francis Chris | BUY | +232,500 | $12.75 | 02/05/2026 | 02/11/2026 |
| BOLNO PAUL | BUY | +165,000 | Not reported | 02/05/2026 | 02/11/2026 |